ScienceDex / Researcher record
Yondola, Mark
- Calder Biosciences, Inc. (no department on record)
- Avatar Medical, LLC (no department on record)
From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.
FY2019 NIH rank #4,406
NIH Funding · FY2019
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2015 | $224,905 | 1 | #29,945 |
| 2016 | $749,449 | 1 | #9,971 |
| 2017 | $749,718 | 2 | #10,152 |
| 2018 | $1,286,491 | 2 | #5,391 |
| 2019 | $1,586,888 | 4 | #4,406 |
| 2020 | $887,615 | 1 | #3,578 |
| 2021 | $989,026 | 1 | #9,429 |
| 2022 | $984,686 | 1 | #10,047 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20151 record
- FY20161 record
- FY20172 records
- FY20182 records
- FY2019 · selected4 records
- FY20201 record
- FY20211 record
- FY20221 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2019 award records by amount
NIH award records listing Yondola, Mark as a PI. Multi-PI records show the full award amount for context.
- 5R44AG059371-03R44Contact PIA Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA$612.3Kaward amount
- 6R44AG059371-04R44Contact PIA Universal Flu Vaccine Based On Conformationally Locked Soluble Headless HA$374.9Kaward amount
- 5R43AI140941-02R43Contact PIAn adjuvant for an RSV prefusion F vaccine that safely protects infants via maternal vaccination$300Kaward amount
- 1R44AG064107-01R44Contact PIAn RSV Prefusion F Vaccine that Overcomes Immunosenescence$299.7Kaward amount
Award organizations
Organizations that administered FY2019 awards listing Yondola, Mark as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardCalder Biosciences, Inc.
- 2016$500K Cumulative Funding
- 2016Entered Top 50% NationallyRanked #9971
- 2016Multi-Institutional ResearchAwards at 2 institutions
- 2017$1M Cumulative Funding
- 2018$2M Cumulative Funding
- 2019Entered Top 25% NationallyRanked #4406
- 2020$5M Cumulative Funding